- Riociguat, an oral soluble guanylate cyclase stimulator, in the treatment of pulmonary hypertension2016 | First Faculty of Medicine
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)2015 | First Faculty of Medicine
- Acute hemodynamic effects of Riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1)2014 | First Faculty of Medicine
- Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension2017 | First Faculty of Medicine
- RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors2017 | First Faculty of Medicine
- Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial2020 | First Faculty of Medicine
- CYSL-1 Interacts with the O-2-Sensing Hydroxylase EGL-9 to Promote H2S-Modulated Hypoxia-Induced Behavioral Plasticity in C. elegans2012 | First Faculty of Medicine
- Gaseous O-2, NO, and CO in Signal Transduction: Structure and Function Relationships of Heme-Based Gas Sensors and Heme-Redox Sensors2015 | Faculty of Science
- Heme: Emergent roles of heme in signal transduction, functional regulation and as catalytic centres2019 | Faculty of Science
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension2013 | First Faculty of Medicine
- Biochemical mechanisms of action of antidepressants2011 | First Faculty of Medicine
- The role of nitric oxide during embryonic epidermis development of Xenopus laevis2017 | Faculty of Science, Central Library of Charles University
- Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial2016 | First Faculty of Medicine
- Chronic thromboembolic pulmonary hypertension2016 | First Faculty of Medicine
- Chronic thromboembolic pulmonary hypertension: role of medical therapy2013 | First Faculty of Medicine
- Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)2020 | First Faculty of Medicine
- Current advances in the treatment of chronic pulmonary hypertension2023 | First Faculty of Medicine
- Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial2021 | First Faculty of Medicine